Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Positive results from Phase II clinical trial of INT-747 announced

Positive results from Phase II clinical trial of INT-747 announced

Comprehensive, risk-based screening guidelines for breast, cervical and colorectal cancers

Comprehensive, risk-based screening guidelines for breast, cervical and colorectal cancers

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Shire reports results of Lialda and 5-ASA persistency analyses

Shire reports results of Lialda and 5-ASA persistency analyses

Patients with Inflammatory Bowel Disease may be at risk for developing non-melanoma skin cancer

Patients with Inflammatory Bowel Disease may be at risk for developing non-melanoma skin cancer

Probiotic therapy can be effective for treating intestinal disorders

Probiotic therapy can be effective for treating intestinal disorders

Pharmos announces results of its Phase 2b Dextofisopam trial

Pharmos announces results of its Phase 2b Dextofisopam trial

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Update from SemBioSys Genetics regarding Botaneco Specialty Ingredients

Update from SemBioSys Genetics regarding Botaneco Specialty Ingredients

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

Sosei Group assigns its SD281 drug discovery programme to Biocopea

Sosei Group assigns its SD281 drug discovery programme to Biocopea

Digestive Health Outcomes Registry for patients with GI disease

Digestive Health Outcomes Registry for patients with GI disease

New findings on genetic disorder may lead to better treatment of inflammatory bowel disease

New findings on genetic disorder may lead to better treatment of inflammatory bowel disease

Pfizer-FRSQ Innovation Fund supports genetic study of inflammatory bowel disease and cancer

Pfizer-FRSQ Innovation Fund supports genetic study of inflammatory bowel disease and cancer

16 Canadian students living with chronic illness to receive UCBeyond Scholarships

16 Canadian students living with chronic illness to receive UCBeyond Scholarships

Mayo study reveals infliximab reduces the need for colectomy

Mayo study reveals infliximab reduces the need for colectomy

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

NIH grants $5 million to Pittsburgh researchers

NIH grants $5 million to Pittsburgh researchers